Alzheimer's disease from researcher to caregiver: a personal journey and call to action.
The devastating impact of Alzheimer's disease (AD) spares no one. Given the economic and societal consequences, research and development for AD is presently witnessing a 'call to action,' yet the unmet needs of patients and caregivers are enormous. Moreover, despite the scientific advances and growing interest in public-private partnerships (PPPs), there are insufficient funds to support current and future PPP initiatives that aim to benefit all stakeholders. This article highlights a journey based on my own professional experiences as a neuroscientist, drug developer, and family member of a loved one suffering from AD. From my perspective, we must share our expertise as scientists and caregivers, our clinical trial data, our drug development tools, and our discoveries - just as we all share the burdens of this dehumanizing disease.